Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Dec 15, 2021; 13(12): 2149-2160
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2149
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2149
Factor | Hepatocellular carcinoma surveillance adherence (PTUDS) | ||
< 60 yr | 60 yr | P value | |
Age | 80.6% | 86.8% | < 0.001 |
Non-cirrhotic | Cirrhotic | ||
Cirrhosis status | 80.1% | 87.3% | < 0.001 |
Non-Asian | Asian | ||
Ethnicity | 85.1% | 81.2% | 0.04 |
English | CALD | ||
Primary language spoken | 85.7% | 80.2% | 0.03 |
Male | Female | ||
Sex | 83.3% | 85.6% | 0.58 |
Treatment naïve | Anti-viral therapy | ||
Hepatitis B treatment status | 79.4% | 82.1% | 0.07 |
- Citation: Low ES, Apostolov R, Wong D, Lin S, Kutaiba N, Grace JA, Sinclair M. Hepatocellular carcinoma surveillance and quantile regression for determinants of underutilisation in at-risk Australian patients. World J Gastrointest Oncol 2021; 13(12): 2149-2160
- URL: https://www.wjgnet.com/1948-5204/full/v13/i12/2149.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i12.2149